|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:218-223
© 2006 The American Association for Thoracic Surgery
Cardiothoracic Transplantation |
a Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Calif
b Division of Pulmonary Medicine, Critical Care and Hospitalists, David Geffen School of Medicine, University of California, Los Angeles, Calif.
Received for publication April 21, 2005; revisions received August 15, 2005; accepted for publication August 30, 2005. * Address for reprints: Gabriel T. Schnickel, MD, Division of Cardiothoracic Surgery, 62-182 CHS, UCLA Medical Center, 10833 Le Conte Ave, Los Angeles, CA 90095. (Email: gschnick{at}ucla.edu).
OBJECTIVE: Severe primary graft dysfunction occurs in 10% to 20% of lung transplant recipients and is the leading cause of early death after lung transplantation. We hypothesized that altering the content of the initial reperfusate and maintaining a low reperfusion pressure after surgical implantation would lead to a low incidence of primary graft dysfunction.
METHODS: We analyzed the records of all patients who underwent lung transplantation at our institution from March 1, 2000, to August 30, 2004. The modified reperfusion technique involved the insertion of a catheter into the main or individual pulmonary artery after implantation. The recipient blood was depleted of leukocytes; supplemented with nitroglycerin; adjusted for pH and calcium level; enriched with aspartate, glutamate, and dextrose; and then administered into the pulmonary arteries of the newly transplanted lung(s) for the first 10 minutes of reperfusion. Severe primary graft dysfunction was defined as a PaO 2/inspired oxygen fraction of less than 150 with diffuse infiltrate on the radiograph in absence of other causes.
RESULTS: During this interval, 100 patients underwent lung transplantation with the modified reperfusion technique. Forty-two patients underwent single-lung transplantation, of which 5 patients required cardiopulmonary bypass for the procedure. Fifty-eight patients underwent double-lung transplantation; all double-lung transplantation procedures were performed with patients on cardiopulmonary bypass. There were no technical complications associated with the modified reperfusion. The mean PaO 2/inspired oxygen fraction at 6 hours in this cohort was 252 ± 123 mm Hg. The median number of days on the ventilator was 2. More importantly, the incidence of severe primary graft dysfunction in this cohort was 2.0%. The early survival (30-day or in-hospital mortality) of this group of patients was 97%.
CONCLUSIONS: The technique of modified reperfusion in human lung transplantation is associated with a low incidence of severe primary graft dysfunction and favorable short-term outcomes.
This article has been cited by other articles:
![]() |
J. C. Lee and J. D. Christie Primary Graft Dysfunction Proceedings of the ATS, January 15, 2009; 6(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mahidhara, S. Bastani, D. J. Ross, R. Saggar, J. Lynch III, G. T. Schnickel, D. Gjertson, R. Beygui, and A. Ardehali Lung transplantation in older patients? J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 412 - 420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |